Interactive Molecular Structure The following interactive 3D visualization renders the tirzepatide peptide backbone in its alpha-helical conformation
In addition, tirzepatide administration reduced the levels of YKL-40 and leptin versus placebo and dulaglutide treatment.37 Tirzepatide treatment at a dose of 15 mg also decreased ICAM-1 levels compared with placebo and dulaglutide administration and reduced high-sensitivity C-reactive protein levels compared with baseline and placebo treatment, but not dulaglutide treatment.37 The mechanism by which tirzepatide reduces these inflammatory markers is not fully understood
Recommended tirzepatide injection sites Approved injection sites are the abdomen, the front of the thighs, and (with a helper) the back of the upper arm
JAMA Dermatol
The company says it's currently pursuing legal action against 'certain medical spas, wellness [centres], and compounding pharmacies' for their false claims
Given the chronic nature of type 2 diabetes and the challenges associated with weight management, tirzepatide has garnered significant attention due to its effectiveness in clinical trials
